Key result
Male sex is linked to ~21% higher odds of receiving DVT prophylaxis compared to women.
Why the study?
Gender differences in the prescription of prophylaxis against deep vein thrombosis in hospitalized patients were not well characterized.
Does male gender affect the likelihood of receiving prophylaxis against deep vein thrombosis in hospitalized patients?
Observational (n=2,619)
Does male gender affect the likelihood of receiving prophylaxis against deep vein thrombosis in hospitalized patients?
Odds Ratio: 1.21 (95% CI 1.03–1.43)
p-value: p=0.021
There is a significant gender disparity in the administration of DVT prophylaxis, with men being more likely to receive preventive treatment than women.
May signal inequity in DVT prophylaxis for hospitalized women; leaves open confirmation of bias versus clinical factors in prospective studies.
We investigated gender differences in the prescription of prophylaxis against deep vein thrombosis (DVT) in 2,619 patients who developed acute DVT while being hospitalized for reasons other than DVT or were diagnosed with acute DVT as outpatients but who had been hospitalized within 30 days prior to DVT diagnosis. Men were 21% more likely than women to receive prophylaxis (OR 1.21, 95% CI 1.03-1.43; p=0.021) after adjusting for DVT risk factors, including surgery, trauma, prior DVT, age, and cancer.
No takes yet. Share an insight, caveat, or question.
Kucher et al. (2005) conducted an observational in Acute deep vein thrombosis (DVT) (n=2,619). Male gender vs. Female gender was evaluated on Prescription of prophylaxis against deep vein thrombosis (OR 1.21, 95% CI 1.03-1.43, p=0.021). Men were 21% more likely than women to receive prophylaxis against deep vein thrombosis (OR 1.21; 95% CI 1.03-1.43; p=0.021).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: